|
|
Volumn 337, Issue 23, 1997, Pages 1693-1694
|
|
Treatment of prostate cancer with goserelin and radiotherapy [1] (multiple letters)
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GOSERELIN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MALE GENITAL TRACT CANCER;
PRIORITY JOURNAL;
PROSTATE CANCER;
TREATMENT OUTCOME;
METHODOLOGY;
MULTIMODALITY CANCER THERAPY;
NOTE;
PATIENT SELECTION;
PROSTATE TUMOR;
ADJUVANT CHEMOTHERAPY;
OUTCOME ASSESSMENT;
ANTINEOPLASTIC AGENTS, HORMONAL;
COMBINED MODALITY THERAPY;
GOSERELIN;
HUMANS;
MALE;
PATIENT SELECTION;
PROSTATIC NEOPLASMS;
RESEARCH DESIGN;
CHEMOTHERAPY, ADJUVANT;
OUTCOME ASSESSMENT (HEALTH CARE);
|
|
EID: 0030664695
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199712043372313 Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|
